Geographic Variation in Medicare Spending and Mortality for Diabetic Patients with Foot Ulcers and Amputations

Overview

Journal J Diabetes Complications

Specialty Endocrinology

Date 2012 Oct 16

PMID 23062327

Citations 35

Authors

Michael R Sargen

Ole Hoffstad

David J Margolis

Affiliations

Soon will be listed here.

Abstract

Aims: The purpose of this study was to identify the presence or absence of geographic variation in Medicare spending and mortality rates for diabetic patients with foot ulcers (DFU) and lower extremity amputations (LEA).

Methods: Diabetic beneficiaries with foot ulcers (n=682,887) and lower extremity amputations (n=151,752) were enrolled in Medicare Parts A and B during the calendar year 2007. We used ordinary least squares (OLS) regression to explain geographic variation in per capita Medicare spending and one-year mortality rates.

Results: Health care spending and mortality rates varied considerably across the nation for our two patient cohorts. However, higher spending was not associated with a statistically significant reduction in one-year patient mortality (P=.12 for DFU, P=.20 for LEA). Macrovascular complications for amputees were more common in parts of the country with higher mortality rates (P<.001), but this association was not observed for our foot ulcer cohort (P=.12). In contrast, macrovascular complications were associated with increased per capita spending for beneficiaries with foot ulcers (P=.01). Rates of hospital admission were also associated with higher per capita spending and increased mortality rates for individuals with foot ulcers (P<.001 for health spending and mortality) and lower extremity amputations (P<.001 for health spending, P=.01 for mortality).

Conclusions: Geographic variation in Medicare spending and mortality rates for diabetic patients with foot ulcers and amputations is associated with regional differences in the utilization of inpatient services and the prevalence of macrovascular complications.

Citing Articles

Prevalence of Diabetic Foot Ulcer and Determinant Factors Among Adult Diabetic Patients Who Attend the Diabetic Follow-Up at Adwa General Hospital, Ethiopia, 2019: A Cross-Sectional Study.

Mekonen H, Gebru T Health Sci Rep. 2024; 7(12):e70238.

PMID: 39720242 PMC: 11667761. DOI: 10.1002/hsr2.70238.

Incidence and predictors of diabetic foot ulcer among patients with diabetes mellitus in a diabetic follow-up clinic in Central Ethiopia: a retrospective follow-up study.

Mekuria Negussie Y, Komicha M, Abebe T BMJ Open. 2024; 14(6):e085281.

PMID: 38908850 PMC: 11328629. DOI: 10.1136/bmjopen-2024-085281.

Development of novel lysosome-related signatures and their potential target drugs based on bulk RNA-seq and scRNA-seq for diabetic foot ulcers.

Tan L, Qu J, Wang J Hum Genomics. 2024; 18(1):62.

PMID: 38862997 PMC: 11165785. DOI: 10.1186/s40246-024-00629-1.

Why Are There So Few FDA-Approved Therapeutics for Wound Healing?.

Chen M, Chang C, Levian B, Woodley D, Li W Int J Mol Sci. 2023; 24(20).

PMID: 37894789 PMC: 10606455. DOI: 10.3390/ijms242015109.

The association between micronutrient levels and diabetic foot ulcer: A systematic review with meta-analysis.

Kurian S, Baral T, Unnikrishnan M, Benson R, Munisamy M, Saravu K Front Endocrinol (Lausanne). 2023; 14:1152854.

PMID: 37065742 PMC: 10090454. DOI: 10.3389/fendo.2023.1152854.

References

Harris M . Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998; 21 Suppl 3:C11-4. DOI: 10.2337/diacare.21.3.c11. View

Zimmet P, Alberti K, Shaw J . Global and societal implications of the diabetes epidemic. Nature. 2001; 414(6865):782-7. DOI: 10.1038/414782a. View

Wilson P, McGee D, Kannel W . Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study. Am J Epidemiol. 1981; 114(5):697-704. DOI: 10.1093/oxfordjournals.aje.a113240. View

Iversen M, Tell G, Riise T, Hanestad B, Ostbye T, Graue M . History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care. 2009; 32(12):2193-9. PMC: 2782976. DOI: 10.2337/dc09-0651. View

Wang Y, McPherson K, Marsh T, Gortmaker S, Brown M . Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011; 378(9793):815-25. DOI: 10.1016/S0140-6736(11)60814-3. View

Sirovich B, Gallagher P, Wennberg D, Fisher E . Discretionary decision making by primary care physicians and the cost of U.S. Health care. Health Aff (Millwood). 2008; 27(3):813-23. PMC: 2438037. DOI: 10.1377/hlthaff.27.3.813. View

Nehler M, Coll J, Hiatt W, Regensteiner J, Schnickel G, Klenke W . Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg. 2003; 38(1):7-14. DOI: 10.1016/s0741-5214(03)00092-2. View

Moulik P, Mtonga R, Gill G . Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003; 26(2):491-4. DOI: 10.2337/diacare.26.2.491. View

Harris M, Flegal K, Cowie C, Eberhardt M, Goldstein D, LITTLE R . Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998; 21(4):518-24. DOI: 10.2337/diacare.21.4.518. View

10.

Sloan F, Bethel M, Ruiz Jr D, Shea A, Shea A, Feinglos M . The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med. 2008; 168(2):192-9. DOI: 10.1001/archinternmed.2007.35. View

11.

Lee H, Choi C, Birkenfeld A, Alves T, Jornayvaz F, Jurczak M . Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab. 2010; 12(6):668-74. PMC: 3013349. DOI: 10.1016/j.cmet.2010.11.004. View

12.

Mayfield J, Reiber G, Maynard C, Czerniecki J, Caps M, Sangeorzan B . Survival following lower-limb amputation in a veteran population. J Rehabil Res Dev. 2001; 38(3):341-5. View

13.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

14.

Helmrich S, Ragland D, Leung R, Paffenbarger Jr R . Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991; 325(3):147-52. DOI: 10.1056/NEJM199107183250302. View

15.

. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008; 31(3):596-615. DOI: 10.2337/dc08-9017. View

16.

Gottlieb D, Zhou W, Song Y, Andrews K, Skinner J, Sutherland J . Prices don't drive regional Medicare spending variations. Health Aff (Millwood). 2010; 29(3):537-43. PMC: 2919810. DOI: 10.1377/hlthaff.2009.0609. View

17.

Aulivola B, Hile C, Hamdan A, Sheahan M, Veraldi J, Skillman J . Major lower extremity amputation: outcome of a modern series. Arch Surg. 2004; 139(4):395-9. DOI: 10.1001/archsurg.139.4.395. View

18.

Sargen M, Hoffstad O, Wiebe D, Margolis D . Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes. J Diabetes Complications. 2012; 26(4):301-7. PMC: 3398217. DOI: 10.1016/j.jdiacomp.2012.04.001. View

19.

Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339(4):229-34. DOI: 10.1056/NEJM199807233390404. View

20.

Niefeld M, Braunstein J, Wu A, Saudek C, Weller W, Anderson G . Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care. 2003; 26(5):1344-9. DOI: 10.2337/diacare.26.5.1344. View